
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MDGL | NASDAQ | USD | Real-time | |
1MDGL | Milan | EUR | Real-time | |
YDO1 | TradeGate | EUR | Delayed |
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Julian Charles Baker | 56 | 2023 | Independent Chairman of the Board |
William J. Sibold | 58 | 2023 | CEO, President & Director |
Rebecca A. Taub | 73 | 2011 | Founder, Senior Scientific & Medical Advisor and Director |
Kenneth M. Bate | 75 | 2016 | Independent Director |
Richard S. Levy | 68 | 2016 | Independent Director |
Paul A. Friedman | 82 | 2016 | Director |
James M. Daly | 63 | 2019 | Independent Director |
Raymond Cheong | 43 | 2023 | Independent Director |
Jacqualyn A. Fouse | 64 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review